<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04554147</url>
  </required_header>
  <id_info>
    <org_study_id>19-009247</org_study_id>
    <secondary_id>5R21MD013490</secondary_id>
    <nct_id>NCT04554147</nct_id>
  </id_info>
  <brief_title>Use of an Innovative Mobile Health Intervention to Improve Hypertension Among African-Americans</brief_title>
  <official_title>Patient-Provider-Community Health Worker Integrated Care Model: Use of an Innovative Mobile Health Intervention to Improve Hypertension Among African-Americans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Minority Health and Health Disparities (NIMHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The project objective is to test the feasibility of delivering health education and&#xD;
      self-management support to African-American patients with uncontrolled hypertension (HTN)&#xD;
      through a culturally-tailored smartphone application (app)-enhanced intervention within&#xD;
      federally qualified health centers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Fostering African-American Improvement in Total Health (FAITH!) Program at Mayo Clinic, a&#xD;
      community-based cardiovascular (CV) health promotion initiative for African-Americans (AAs)&#xD;
      will collaborate with the Minnesota Department of Health (MDH) Cardiovascular Health Unit and&#xD;
      two federally qualified health centers (FQHCs) (NorthPoint Health &amp; Wellness Center,&#xD;
      Minneapolis, MN; Open Cities Health Center, St. Paul, MN) to integrate an innovative mobile&#xD;
      health (mHealth) intervention (FAITH! HTN App) into clinical and community settings with the&#xD;
      aim of improving blood pressure (BP) control.&#xD;
&#xD;
      The project objective is to test the feasibility of delivering health education and&#xD;
      self-management support to African-American patients with uncontrolled hypertension (HTN)&#xD;
      through a culturally-tailored smartphone application (app)-enhanced intervention within&#xD;
      federally qualified health centers. This initiative is a component of a Centers for Disease&#xD;
      Control and Prevention (CDC) effort to support state/local public health strategies to&#xD;
      prevent and manage cardiovascular disease (CVD) in under-resourced populations&#xD;
      disproportionately affected by CVD risk factors, such as HTN. Insights from the FAITH!&#xD;
      Community Steering Committee (CSC) will also provide guidance to ensure project&#xD;
      patient-centeredness. The investigators will incorporate strategies grounded in theoretical&#xD;
      frameworks to ensure soundness of our intervention while tailoring it to meet the preferences&#xD;
      and needs of an under-resourced population with multi-level barriers to HTN management.&#xD;
&#xD;
      Specific Aim 1:To assess app feasibility through participant intervention engagement (app&#xD;
      education module completion, self-monitoring) and intervention satisfaction.&#xD;
&#xD;
      Specific Aim 2: To assess preliminary efficacy of the app by evaluating improvement in&#xD;
      patient BP control (immediate, 3 months and 6 months post-intervention), CV health knowledge&#xD;
      (via app self-assessments), and BP self-management (medication adherence).&#xD;
&#xD;
      Hypothesis:&#xD;
&#xD;
      The study hypothesis is that an app-based intervention will be feasible and demonstrate&#xD;
      preliminary efficacy in improving uncontrolled HTN and health education among AA patients&#xD;
      from baseline to post-intervention (immediate, 3 months and 6 months post-intervention).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 15, 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This is a nonrandomized, single arm feasibility study testing the preliminary efficacy of an app-enhanced intervention with a patient-provider-community health worker triad to promote hypertension control among AA patients within FQHCs.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure (systolic and diastolic, mmHg)</measure>
    <time_frame>0 months post intervention</time_frame>
    <description>Change from baseline blood pressure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood pressure (systolic and diastolic, mmHg)</measure>
    <time_frame>3 months post intervention</time_frame>
    <description>Change from baseline blood pressure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood pressure (systolic and diastolic, mmHg)</measure>
    <time_frame>6 months post intervention</time_frame>
    <description>Change from baseline blood pressure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intervention Feasibility Measures - Participant Engagement with Self-Monitoring</measure>
    <time_frame>Immediate post-intervention</time_frame>
    <description>Participant engagement with weekly blood pressure tracking measured by number of times participant engaged with the blood pressure feature</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intervention Feasibility Measures - Participant Engagement with Self-Monitoring</measure>
    <time_frame>Time Frame: 3 months post-intervention</time_frame>
    <description>Participant engagement with weekly blood pressure tracking measured by number of times participant engaged with the blood pressure feature</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intervention Feasibility Measures - Participant Engagement with Self-Monitoring</measure>
    <time_frame>Time Frame: 6 months post-intervention</time_frame>
    <description>Participant engagement with weekly blood pressure tracking measured by number of times participant engaged with the blood pressure feature</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HTN Self-Care Measures - Participant HTN self-care activities using the H-SCALE (Hypertension Self-Care Activity Level Effects)</measure>
    <time_frame>Immediate post-intervention</time_frame>
    <description>The 31-item instrument assess 6 HTN behavioral self-care activities recommended for optimal HTN management</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HTN Self-Care Measures - Participant HTN self-care activities using the H-SCALE (Hypertension Self-Care Activity Level Effects)</measure>
    <time_frame>3 months post-intervention</time_frame>
    <description>The 31-item instrument assess 6 HTN behavioral self-care activities recommended for optimal HTN management</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HTN Self-Care Measures - Participant HTN self-care activities using the H-SCALE (Hypertension Self-Care Activity Level Effects)</measure>
    <time_frame>6 months post-intervention</time_frame>
    <description>The 31-item instrument assess 6 HTN behavioral self-care activities recommended for optimal HTN management</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Preliminary Efficacy of Intervention - CV Health Knowledge as measured by module assessment scores</measure>
    <time_frame>Immediate post intervention</time_frame>
    <description>Change in percentage correct scores (pre- and post- self-assessments) for each education module by patient and as a conglomerate (mean) for all patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Social Determinants of Health (SDOH, PRAPARE (Protocol for Responding to and Addressing Patient Assets, Risks, and Experiences) tool)</measure>
    <time_frame>Immediate post-intervention</time_frame>
    <description>Change from baseline PRAPARE score. The PRAPARE assessment tool will be used to calculate a tally risk score indicating the cumulative number of SDOH risks a patient faces (including 15 SDOH domains).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preliminary Efficacy of Intervention - BP Self-Management: Self-efficacy for HTN management</measure>
    <time_frame>Immediate post-intervention</time_frame>
    <description>Change from baseline score. Self-efficacy to change health behaviors to manage HTN as measured by a 5-item instrument.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self Efficacy for Medication Adherence as measured by the MASES scale (medication adherence self-efficacy scale)</measure>
    <time_frame>Immediate post-intervention</time_frame>
    <description>Change from baseline score. The 13-item instrument assesses patients' confidence in their ability to take their BP medications in a variety of situations.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Intervention Feasibility Measures - Participant Engagement with Sharing Board</measure>
    <time_frame>Immediate post-intervention</time_frame>
    <description>Participant engagement with sharing board measured by number of posts per week by each participant</description>
  </other_outcome>
  <other_outcome>
    <measure>Intervention Feasibility Measures - Participant Engagement with Sharing Board</measure>
    <time_frame>3 months post-intervention</time_frame>
    <description>Participant engagement with sharing board measured by number of posts per month by each participant</description>
  </other_outcome>
  <other_outcome>
    <measure>Intervention Feasibility Measures - Participant Engagement with Sharing Board</measure>
    <time_frame>6 months post-intervention</time_frame>
    <description>Participant engagement with sharing board measured by number of posts per month by each participant</description>
  </other_outcome>
  <other_outcome>
    <measure>Intervention Feasibility Measures - Participant Engagement with Modules</measure>
    <time_frame>Immediate post-intervention</time_frame>
    <description>Participant engagement with education modules measured by number of modules completed out of 10</description>
  </other_outcome>
  <other_outcome>
    <measure>Intervention Satisfaction Measures - Participant Satisfaction with FAITH! HTN App</measure>
    <time_frame>Immediate post-intervention</time_frame>
    <description>Participant satisfaction with FAITH! HTN App measured by the Health Information Technology Usability Evaluation Scale (Health-ITUES). 20 items are assessed, each on a 5-point scale ranging from 1 (strongly disagree) to 5 (strongly agree). A higher total sum indicates higher perceived usability of the technology.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>High Blood Pressure</condition>
  <arm_group>
    <arm_group_label>FAITH! App-enhanced Hypertension Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>FAITH! HTN App: The program promotes HTN self-management through a 10-week education module series on HTN. Participants will follow each module weekly and use a wireless home BP monitor for self-tracking which syncs to the app. The app includes module quizzes, a BP tracking dashboard and a moderated sharing board to foster discussion on HTN management.&#xD;
Patient-Provider-CHW ICM. The patient-provider-CHW triad works together for personalized, collaborative goal setting. The patient will complete app modules, self-monitor BP, and engage with a sharing board integrating HTN topics. At weekly virtual visits (telephone or video), the CHW will record patient BPs, assist with addressing social determinants of health (SDOH) identified by the patient (eg, local community resources), and review HTN modules. The CHW will upload clinical/SDOH data to the patient electronic medical record (EMR) for FQHC care providers to review. This cycle will be completed weekly over the 10-week intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>FAITH! App-enhanced Hypertension Intervention</intervention_name>
    <description>FAITH! HTN App: The program promotes HTN self-management through a 10-week education module series on HTN. Participants will follow each module weekly and use a wireless home BP monitor for self-tracking which syncs to the app. The app includes module quizzes, a BP tracking dashboard and a moderated sharing board to foster discussion on HTN management.&#xD;
Patient-Provider-CHW ICM. The patient-provider-CHW triad works together for personalized, collaborative goal setting. The patient will complete app modules, self-monitor BP, and engage with a sharing board integrating HTN topics. At weekly virtual visits (telephone or video), the CHW will record patient BPs, assist with addressing social determinants of health (SDOH) identified by the patient (eg, local community resources), and review HTN modules. The CHW will upload clinical/SDOH data to the patient electronic medical record (EMR) for FQHC care providers to review. This cycle will be completed weekly over the 10-week intervention.</description>
    <arm_group_label>FAITH! App-enhanced Hypertension Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  African American race/ethnicity&#xD;
&#xD;
          -  18 years or older&#xD;
&#xD;
          -  Receive primary care at one of the two partnering Federally Qualified Health Centers&#xD;
             (FQHC) and intent to continue care there for next 6 months&#xD;
&#xD;
          -  Uncontrolled HTN (defined as BP â‰¥140/90 mmHg [as per JNC7 Hypertension Guidelines68]&#xD;
             at most recent outpatient evaluation, with or without BP medications)&#xD;
&#xD;
          -  Documented diagnosis of HTN in EHR&#xD;
&#xD;
          -  At least 1 office visit at one of the two partnering FQHCs in prior year&#xD;
&#xD;
          -  Smartphone ownership (supporting iOS or Android Systems)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to commit to participating in both focus groups (pre and post app refinement).&#xD;
&#xD;
          -  Diagnosis of a serious medical condition or disability that would make participation&#xD;
             difficult (i.e. visual or hearing impairment, mental disability that would preclude&#xD;
             independent use of the app).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>LaPrincess C Brewer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>North Point Health &amp; Wellness Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55411</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Open Cities Health Center</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 12, 2020</study_first_submitted>
  <study_first_submitted_qc>September 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 18, 2020</study_first_posted>
  <last_update_submitted>October 27, 2021</last_update_submitted>
  <last_update_submitted_qc>October 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>LaPrincess C. Brewer</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>health disparities</keyword>
  <keyword>mobile health</keyword>
  <keyword>community health</keyword>
  <keyword>African-Americans</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 1, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/47/NCT04554147/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

